In July 2021, President Biden issued Executive Order 14036, “Promoting Competition in the American Economy.” The order includes 72 initiatives designed to address competition issues across the US economy, several related to the healthcare system, prescription drugs, and hospital mergers.

Managing Director Dr. Subramaniam (Subbu) Ramanarayanan spoke on Epstein Becker Green’s Diagnosing Healthcare podcast with attorneys John Steren, Patricia Wagner, and Dan Fahey to discuss how mergers and acquisitions in the hospital industry are being impacted by President Biden’s Executive Order. After the Executive Order was announced, the Federal Trade Commission announced policy changes and the Department of Justice has been asked to consider policy changes that boards of directors and C-suite officers may want to consider when weighing transactions.

The podcast is available on your preferred platform: Apple Podcasts, Google Podcasts, Overcast, and Spotify.